Los puntos clave no están disponibles para este artículo en este momento.
Breast cancer in men accounts for about 1% of all breast cancers and is mainly estrogen-receptor–positive. Few prospective studies of treatment in men have been performed, so management is based largely on extrapolation from results in postmenopausal women.
Sharon H. Giordano (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: